Effects of phenobarbitone on serum biochemical tests in dogs

Australian Veterinary Journal

Volumn 78, Issue 1, 2000, Pages 23-26

  Foster, S F ^a   Church, D B ^a   Watson, A D J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Alanine aminotransferase; Alkaline phosphatase; Dog; Gamma glutamyl transferase; Hypertriglyceridaemia; Phenobarbitone

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTICONVULSIVE AGENT; BILIRUBIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; PHENOBARBITAL; PLASMA PROTEIN; SERUM ALBUMIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; FEMALE; MALE; SEIZURE;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ANTICONVULSANTS; BILIRUBIN; BLOOD CHEMICAL ANALYSIS; BLOOD PROTEINS; CHOLESTEROL; DOG DISEASES; DOGS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; MALE; PHENOBARBITAL; SEIZURES; SERUM ALBUMIN;

EID: 0033631963     PISSN: 00050423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-0813.2000.tb10350.x     Document Type: Article

References (24)

1. Schwartz-Porsche D, Löscher W, Frey H-H. Therapeutic efficacy of phenobarbital and primidone in canine epilepsy: a comparison. J Vet Pharmacol Therap 1985;8:113-119.
2. Meric Taylor S. Seizures. In: Nelson RW, Couto CG, editors. Essentials of small animal internal medicine. 2nd edn. Mosby Year Book, St Louis, 1998:988-1001.
3. Dayrell-Hart B, Steinberg SA, Van Winkle TJ, Farnbach GC. Hepatotoxicity of phenobarbital in dogs: 18 cases (1985-1989). J Am Vet Med Assoc 1991;199:1060-1066.
4. Bunch SE. Hepatobiliary diseases in the dog. In: Nelson RW, Couto CG, editors. Essentials of small animal internal medicine. 2nd edn. Mosby Year Book, St Louis, 1998:529-547.
5. Center SA. Pathophysiology and laboratory diagnosis of hepatobiliary disorders. In: Ettinger SJ, Feldman EC, editors. Textbook of veterinary internal medicine. 4th edn. Saunders, Philadelphia, 1995:1261-1312.
6. Meyer DJ, Noonan NE. Liver tests in dogs receiving anticonvulsant drugs (diphenylhydantoin and primidone). J Am Anim Hosp Assoc 1981;17:261-264.
7. Bunch SE, Baldwin BH, Hornbuckle WE, Tennant BC. Compromised hepatic function in dogs treated with anticonvulsant drugs. J Am Vet Med Assoc 1984;184:444-448.
8. Bunch SE, Castleman WL, Baldwin BH et al. Effects of long-term primidone and phenytoin administration on canine hepatic function and morphology. Am J Vet Res 1985;46:105-115.
9. Sturtevant F, Hoffmann WE, Dorner JL. The effect of three anticonvulsant drugs and ACTH on canine serum alkaline phosphatase. J Am Anim Hosp Assoc 1977;13:754-757.
10. Balazs T, Farber TM, Feuer G. Drug-induced changes in serum alkaline phosphatase and alanine aminotransferase activities not related to hepatic injuries. Arch Toxicol 1978; (Suppl 1):159-163.
11. Chauvet AE, Feldman EC, Kass PH. Effects of phenobarbital administration on results of serum biochemical analyses and adrenocortical function tests in epileptic dogs. J Am Vet Med Assoc 1995;207:1305-1307.
12. Litchfield MH, Conning DM. Effect of phenobarbitone on plasma and hepatic alkaline phosphatase activity in the dog. Naunyn-Schmiedeberg's Arch Pharmacol 1972;272:358-362.
13. Dyer KR, Monroe WE, Forrester SD. Effects of phenobarbital administration on endogenous ACTH, ACTH response test, alkaline phosphatase isoenzymes, and bile acid metabolism. J Vet Intern Med 1992;6:110.
14. Foster SF, Church DB, Watson ADJ. Effect of phenobarbitone on the low-dose dexamethasone suppression test and urinary corticoid: creatinine ratio in dogs. Aust Vet J 2000;78:19-23.
15. Woodbury DM, Pippenger CE. Other antiepileptic drugs. In: Woodbury DM, Penry JK, Pippenger CE, editors. Antiepileptic drugs. Raven Press, New York, 1982:791-801.
16. Johnson SE. Diseases of the liver. In: Ettinger SJ, Feldman EC, editors. Textbook of veterinary internal medicine. 4th edn. Saunders, Philadelphia, 1995:1313-1357.
17. Trepanier LA. Use of bromide as an anticonvulsant for dogs with epilepsy. J Am Vet Med Assoc 1995;207:163-166.
18. Bunch SE, Conway MB, Center SA et al. Toxic hepatopathy and intrahepatic cholestasis associated with phenytoin administration in combination with other anticonvulsant drugs in three dogs. J Am Vet Med Assoc 1987;190:194-198.
19. Parent JM. Clinical management of canine seizures. Vet Clin North Am Small Anim Pract 1988;18:605-622.
20. Willard MD, Twedt DC. Gastrointestinal, pancreatic, and hepatic disorders. In: Willard MD, Tvedten H, Turnwald GH, editors. Small animal clinical diagnosis by laboratory methods. 2nd edn. Saunders, Philadelphia, 1994:179-218.
21. Burkhard MJ, Meyer DJ. Causes and effects of interference with clinical laboratory measurements and examinations. In: Bonagura JD, Kirk RW, editors. Kirk's current veterinary therapy XII. Saunders, Philadelphia, 1995:14-20.
22. Teske E, Rothuizen J, de Bruijne JJ, Rijnberk A. Corticosteroid-induced alkaline phosphatase isoenzyme in the diagnosis of canine hypercorticism. Vet Rec 1989;125:12-14.
23. Harry DS, Owen JS, McIntyre N. Plasma lipoproteins and the liver. In: Wright R. Millward-Sadler GH, Alberti KGMM, Karan S, editors. Liver and biliary disease. 2nd edn. Ballière Tindall. London, 1985:65-85.
24. Ford RB. Canine hyperlipidemia. In: Ettinger SJ, Feldman EC, editors. Textbook of veterinary internal medicine. 4th edn. Saunders, Philadelphia, 1995:1414-1419.